VeraSci recently welcomed Mark Skeen, MD as Senior Medical Scientist. In this role Dr. Skeen will provide disease state expertise for a broad range of neurologic diseases as well as the perspective of the clinician conducting clinical trials. As part of his role at...
LSK BioPharma (or “LSKB”), a US-based biopharmaceutical firm and Jiangsu Hengrui Medicine, Co., Ltd. (SHA:600276, or “Hengrui”), one of the largest and most innovative fully-integrated biopharmaceutical companies based in China, today announced...
Soliton, Inc., (NASDAQ: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”),...
Alignment with FDA on a single, pivotal, 12-week, placebo-controlled, Phase 3 clinical trial to initiate in the second half of 2019 Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the successful completion of End-of-Phase 2 interactions with the U.S. Food and...
Being chosen as the physical location for a clinical trial is an exciting endeavor. You’ll be responsible for the reputation of the trial, patient interaction, and even have the opportunity to foster relationships with the research sponsor. Clinical trial...
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment milestone in its continuing Phase II Clinical Trial for critical limb ischemia (“CLI”). Enrollment rates have increased...
Email
Text